Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to investigate the tolerability and safety of AZD 1236
compared with placebo ("inactive substance") in COPD patients by assessment of Adverse
Events, vital signs and laboratory safety assessments.